Radiolabeled metaiodobenzylguanidine (MIBG) is sensitive and specific for detecting neuroblastoma. The extent of MIBG-avid disease is assessed using Curie scores. Although …

Recently, a semiquantitative mIBG scoring method (Curie score) has been developed. The aim of this study was to correlate mIBG score with outcome. Methods: Newly diagnosed patients …

Metaiodobenzylguanidine, a guanithidine analog, labeled with 123 I and 131 I, is used for imaging and therapy of neuroblastomas and various neural crest tumors like paragangliomas, …

2021年6月11日 · 收集 123 I-MIBG 平面显像和SPECT/ CT 断层显像的 Curie 评分,以病理结果、其他相关的影像学检查及临床随访为神经母细胞瘤病灶诊断的依据,分别比较两种显像方式的差 …

Radiolabeled metaiodobenzylguanidine (mIBG) is a highly sensitive and specific marker for detecting neuroblastoma. A semiquantitative mIBG score (Curie score [CS]) was assessed for …

Radiolabeled metaiodobenzylguanidine (mIBG) is a highly sen-sitive and specific marker for detecting neuroblastoma. A semi-quantitative mIBG score (Curie score [CS]) was assessed for …

2018年9月10日 · Radiolabeled metaiodobenzylguanidine (MIBG) is sensitive and specific for detecting neuroblastoma. The extent of MIBG‐avid disease is assessed using Curie scores. …

2016年1月12日 · MIBG uptake is seen in 90% of neuroblastomas, identifying both the primary tumor and sites of metastatic disease. The addition of single photon emission computed …

2021年12月9日 · Metaiodobenzylguanidine (MIBG) scans are a radionucleotide imaging modality that undergo Curie scoring to semiquantitatively assess neuroblastoma burden, which can be …

I-131 mIBG Curie and SIOPEN scores have prognostication value in stage 4 neuroblastoma and should be routinely applied. Higher scores predict unfavorable prognosis. Keywords: I-131 …